Posted on 07/22/2021 8:40:58 PM PDT by SeekAndFind
The vaccine advisory panel to the Centers for Disease Control and Prevention (CDC) said on Thursday that the benefits of Johnson & Johnson’s COVID-19 vaccine still outweigh the risk of a serious, but rare, neurological disorder following vaccination.
The Advisory Committee on Immunization Practices met to discuss the incidence of Guillain-Barré syndrome (GBS) following a J&J shot and agreed that the vaccine should continue to be used in people 18 and older under the Food and Drug Administration’s (FDA) emergency use authorization, saying that the vaccine’s benefits far outweigh the risks.
GBS is a condition where the individual’s immune system attacks the body’s nerve cells, causing numbness, pain, and muscle weakness. In severe cases, it can progress to paralysis. An estimated 3,000 to 6,000 cases of GBS are reported annually in the United States with most people making a full recovery, “but some have permanent nerve damage,” according to Dr. Mathew Daley of the advisory panel’s COVID-19 Vaccines Work Group.
However, cases of GBS after a J&J vaccine were higher than expected in the general population with 8.1 cases per one million doses. This was also higher than reported cases of GBS after receiving the messenger RNA vaccines: 1.21 cases per one million for the Moderna vaccine and 1.05 cases per million for the Pfizer vaccine.
About 100 cases of GBS were reported within 42 days following vaccination with a J&J vaccine on the Vaccine Adverse Event Reporting System (VAERS) as of June 30. Around 12.6 million doses of the vaccine have been administered.
Of the 100 cases, 95 were serious and required hospitalization, with 10 patients needing a ventilator and one death 25 days post-vaccination of a 57-year-old man with a medical history of stroke, heart failure, high blood pressure, and diabetes.
According to a presentation by Dr. Meghna Alimchandani of the FDA, 83 percent of the cases occurred in patients aged 18 to 64 years, with the risk of GBS being highest in males and a median onset time of 13 days.
While 84 percent of the cases occurred in the 21-day risk window used for assessment, “the majority of the cases, 98 percent, occurred in that 42-day risk window,” Alimchandani said. Two cases were not included in the timeframe as one occurred outside the 42-day window and the other didn’t specify the onset of the condition.
Alimchandani said the FDA was still in the process of trying to collect the medical records of the 100 reported cases, and additional follow-up information was still forthcoming. So far, only seven cases have been verified.
The federal health regulator has updated the emergency use authorization fact sheet for the J&J vaccine on July 12, warning vaccine providers and recipients that the vaccine is linked to the neurological disorder.
The European Medicines Agency (EMA) announced Thursday that Guillain-Barré syndrome will be listed as a “very rare side effect” of the Johnson & Johnson COVID-19 vaccine, and “a warning will be included in the product information to raise awareness among healthcare professionals and people taking the vaccine.”
The EMA’s safety committee said a causal relationship between the J&J vaccine and GBS was possible after reviewing the available evidence.
“Vaccinated people are advised to seek immediate medical attention if they develop signs and symptoms suggestive of GBS, such as weakness in the extremities, double vision, or difficulty moving eyes,” the EMA said in a statement.
Despite the added warning of GBS, the European regulator said the benefits of the Johnson & Johnson COVID-19 vaccine continue to outweigh the risks of the vaccine.
Guillain-Barré syndrome has been reported following other vaccines, including the annual influenza vaccine, the 1976 swine flu vaccine, and the zoster vaccine. While a causal relationship has not been established between the zoster vaccine and GBS, a warning has been added to the “package insert due to around three to six excess GBS cases per one million doses administered to persons [65 and older] in the six weeks after vaccination.”
Johnson & Johnson did not reply to a request for comment.
CDC CCP what’s the difference?
They can hold that opinion.
I continue to hold mine.
I continue to remain in the control group. Every valid experiment needs a control group.
“You’re not going to get COVID if you have these vaccinations.”
There are a whole bunch of different “rare side effects”....
if they focus on just one at a time it minimizes the experimental nature and true risk of the vaccines...
Equally importantly, Big Pharma is indemnified from the financial risk of their very dangerous product—great scam if you can get away with it.
yep
and the people permanently injured are finding that out now
The same Johnson and Johnson that gave us Levaquin (by other names as well). The side affects of this drug has caused pain and suffering in many people. https://injuryhelpdesk.com/levaquin-lawsuits-victims-of-dangerous-side-effects/
Bkmk
Too bad he can’t be sued if some idiot believes him and dies from Covid. The Dumbocrats would be threatening to sue if Trump said it though. At the very least FB needs to slap a label on his remarks.
There are at least two other prominent vaccines out there. Does CCP accord them equal status?
Not interested in being that “one in a million”, thanks.
GBS affected people with the rush to vaccinate Swine Flu in the ‘70s. Why there was such a fear of Swine Flu (besides being the basis of the Spanish Flu) I don’t know.
BTW, we still haven’t reached the level of Spanish Flu.
Somehow I fail to be convinced.
Throw some Johnson & Johnson talcum powder on it and it’ll be just fine.
The vaccine industry is pure evil and fraudulent
The Benefits of Johnson & Johnson COVID-19 Vaccine
******************************************************************************************
The existing vaccines are worthless for building perfected immunity since the data is that the nucleocapsid section, which the vaccines do not code, is where most of the pre-existing resistance against serious disease resides.
81% of the population had existing immunity before any JABs and further, that immunity is strengthened, materially so, by natural infection.
From a public health perspective you want those people who are not going to be seriously harmed to get it naturally, not take as JAB because it is that enhanced immunity that stops the disease from being of harm to the public on a durable basis.
Additionally, Dr. McCullough has stated that if you have not already had the Coof, your chances of getting it now are less than 1%.
And he stated that the treatment he has used was shown to reduce the need for hospitalization and death by 85% when used early.
I think it is criminal to just tell someone go home and come back when you are so sick you can’t breathe.
This headline is just another lie. The benefit at this point certainly doesn’t outweigh the risk.
Using the past standards-after 5 unexplained deaths there would have been a black box warning. And after 50 deaths, it would have been pulled from the market.
Trying to vaccinate your way out of a pandemic is stupid. There’s a reason that the flu vaccine is administered before flu season.
Yes, the gig is up.
And don’t forget that they knew for decades about the asbestos in baby powder. BABY powder — you really gotta be skeptical of a company that is ok with risking a baby’s health.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.